Breaking News: Embargoed Feed - hidden

Filters close
26-Apr-2024 3:00 PM EDT
Glaucoma Research Foundation establishes Strategic Advisory Council
Glaucoma Research Foundation

The prestigious group brings together key industry leaders and members of the corporate community dedicated to glaucoma patient care.

Query Closed
Reporter's Deadline Passed
24-Apr-2024 3:35 PM EDT
I would like to speak - Amaiya Howard, wdbj7
Newswise Expert Queries

I would like to speak with Cayce Myers about the TikTok ban and how the

   
Newswise: Homelessness a Major Issue for Many Patients in the Emergency Department
26-Apr-2024 10:05 AM EDT
Homelessness a Major Issue for Many Patients in the Emergency Department
Vanderbilt University Medical Center

Housing insecurity is an issue for 1 in 20 patients who go to emergency departments at major medical centers in the Southeast, according to a Vanderbilt University Medical Center (VUMC) study published in JAMA Network Open.

Newswise: MD Anderson and RUSH Unveil RUSH MD Anderson Cancer Center
26-Apr-2024 11:00 AM EDT
MD Anderson and RUSH Unveil RUSH MD Anderson Cancer Center
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and RUSH University System for Health today announced a partnership to create RUSH MD Anderson Cancer Center.

25-Apr-2024 12:05 PM EDT
Undocumented Latinx patients got COVID-19 vaccine at same rate as U.S. citizens
University of California, Los Angeles (UCLA), Health Sciences

For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found.

25-Apr-2024 4:05 PM EDT
Colson Whitehead to Receive the 2025 St. Louis Literary Award
Saint Louis University

Pulitzer Prize-winning author Colson Whitehead will receive the 2025 St. Louis Literary Award from Saint Louis University. Whitehead will come to St. Louis next spring to accept the award.

access_time Embargo lifts in 2 days
This news release is embargoed until 29-Apr-2024 11:00 AM EDT Released to reporters: 26-Apr-2024 9:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 1-May-2024 8:00 AM EDT Released to reporters: 26-Apr-2024 8:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-May-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 29-Apr-2024 5:00 AM EDT Released to reporters: 26-Apr-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 29-Apr-2024 11:00 AM EDT Released to reporters: 26-Apr-2024 1:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 29-Apr-2024 5:00 AM EDT Released to reporters: 25-Apr-2024 8:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Query Closed
Reporter's Deadline Passed
19-Apr-2024 10:22 AM EDT
I'm looking to speak - Neil A Osterweil, Cancer Therapy Advisor
Newswise Expert Queries

I'm looking to speak with a director of research integrity who would be willing

access_time Left Before Reporter's Deadline
Reporter's Deadline: 15-May-2024 7:00 PM EDT
25-Apr-2024 6:57 PM EDT
I am a California-based - Lance William Frazer, Ad Astra Magazine

I am a California-based writer currently working on an assignment for Ad Astra magazine (

Newswise: These jacks-of-all-trades are masters, too: Yeast study helps answer age-old biology question
19-Apr-2024 2:05 PM EDT
These jacks-of-all-trades are masters, too: Yeast study helps answer age-old biology question
University of Wisconsin–Madison

The results, published April 26 in the journal Science, suggest that internal — not external — factors are the primary drivers of variation in the types of carbon yeasts can eat, and the researchers found no evidence that metabolic versatility, or the ability to eat different foods, comes with any trade-offs. In other words, some yeasts are jacks-of-all-trades and masters of each.

access_time Embargo lifts in 2 days
This news release is embargoed until 1-May-2024 12:05 AM EDT Released to reporters: 25-Apr-2024 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-May-2024 12:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 30-Apr-2024 11:00 AM EDT Released to reporters: 25-Apr-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Apr-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 29-Apr-2024 12:00 PM EDT Released to reporters: 25-Apr-2024 12:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 12:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 29-Apr-2024 12:00 PM EDT Released to reporters: 25-Apr-2024 12:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 12:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 1-May-2024 4:00 PM EDT Released to reporters: 25-Apr-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-May-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Cancer Survivors Reporting Loneliness Experience Higher Mortality Risk, New Study Shows
23-Apr-2024 12:00 PM EDT
Cancer Survivors Reporting Loneliness Experience Higher Mortality Risk, New Study Shows
American Cancer Society (ACS)

A new study led by researchers at the American Cancer Society (ACS) showed people surviving cancer who reported feeling more lonely experienced a higher mortality risk compared to survivors reporting low or no loneliness.

access_time Embargo lifts in 2 days
This news release is embargoed until 29-Apr-2024 5:00 AM EDT Released to reporters: 25-Apr-2024 5:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds
22-Apr-2024 3:05 PM EDT
Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds
University of California, Los Angeles (UCLA), Health Sciences

A new UCLA Health study found certain genetic variants could help explain how long-term pesticide exposure could increase the risk of Parkinson’s disease.

18-Apr-2024 4:05 PM EDT
Future Parents More Likely to Get RSV Vaccine When Pregnant if Aware That RSV Can Be a Serious Illness in Infants
Ann and Robert H. Lurie Children's Hospital of Chicago

A nationwide survey of people who were pregnant or trying to become pregnant found that overall 54 percent expressed interest in the RSV vaccine during pregnancy. Perceiving RSV as a serious illness in infants was the strongest predictor of likely vaccination during pregnancy. Likelihood to receive the RSV vaccine during pregnancy was also higher among parents with a child at home already. Findings were published in the journal Pediatrics.

23-Apr-2024 7:05 AM EDT
It’s easier now to treat opioid addiction with medication -- but use has changed little
Michigan Medicine - University of Michigan

In the first year after the sudden removal of a requirement that prescribers get special permission to prescribe medication for opioid addiction, a study finds more prescribers started providing it, but the number of patients receiving it didn't rise very much.

24-Apr-2024 2:05 PM EDT
Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease
Children's Hospital of Philadelphia

An international consortium published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).

18-Apr-2024 9:05 AM EDT
Use of Acid Reflux Drugs Linked to Higher Risk of Migraine
American Academy of Neurology (AAN)

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology. The acid-reducing drugs include proton pump inhibitors such as omeprazole and esomeprazole, histamine H2-receptor antagonists, or H2 blockers, such as cimetidine and famotidine, and antacid supplements.

18-Apr-2024 9:05 AM EDT
For Immigrants to Canada, Risk of MS Increases with Proportion of Life Spent There
American Academy of Neurology (AAN)

Immigrants to Canada who have spent a greater proportion of their lives in Canada have a greater risk of developing multiple sclerosis (MS) than people who have spent a smaller proportion of their lives there, according to a study published in the April 24, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that an increased proportion of life in Canada causes MS; it only shows an association.

access_time Embargo lifts in 2 days
This news release is embargoed until 29-Apr-2024 8:00 AM EDT Released to reporters: 24-Apr-2024 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

22-Apr-2024 1:05 PM EDT
CHOP Researchers Discover Underlying Biology Behind Fontan-Associated Liver Disease
Children's Hospital of Philadelphia

As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children’s Hospital of Philadelphia (CHOP) used state-of-the-art technologies to understand the underlying biology of Fontan-associated liver disease (FALD).

Newswise: Laser technology offers breakthrough in detecting illegal ivory
23-Apr-2024 7:05 AM EDT
Laser technology offers breakthrough in detecting illegal ivory
University of Bristol

A new way of quickly distinguishing between illegal elephant ivory and legal mammoth tusk ivory could prove critical to fighting the illegal ivory trade. A laser-based approach developed by scientists at the Universities of Bristol and Lancaster, could be used by customs worldwide to aid in the enforcement of illegal ivory from being traded under the guise of legal ivory.

Newswise:Video Embedded a-flexible-microdisplay-can-monitor-brain-activity-in-real-time-during-brain-surgery
VIDEO
23-Apr-2024 7:00 AM EDT
A Flexible Microdisplay Can Monitor and Visualize Brain Activity in Real-time During Brain Surgery
University of California San Diego

A thin film that combines an electrode grid and LEDs can both track and produce a visual representation of the brain’s activity in real-time during surgery–a huge improvement over the current state of the art.

Newswise: Mount Sinai Researchers the First to Apply Single-Cell Analysis to Reveal Mechanisms of a Common Complication of Crohn’s Disease
22-Apr-2024 1:00 PM EDT
Mount Sinai Researchers the First to Apply Single-Cell Analysis to Reveal Mechanisms of a Common Complication of Crohn’s Disease
Mount Sinai Health System

Study identifies key pathways underlying perianal fistula, a disease complication that is more prevalent and severe in African Ameri can populations

Query Closed
Reporter's Deadline Passed
22-Apr-2024 10:12 AM EDT
I'm working on a - Joni Sweet, Sleep.com
Newswise Expert Queries

I'm working on a story for Sleep.com about how video games affect sleep.

     
Newswise: Modeling broader effects of wildfires in Siberia
18-Apr-2024 9:00 PM EDT
Modeling broader effects of wildfires in Siberia
Hokkaido University

As wildfires in Siberia become more common, global climate modeling estimates significant impacts on climate, air quality, health, and economies in East Asia and across the northern hemisphere.

Newswise: This salt battery harvests osmotic energy where the river meets the sea
19-Apr-2024 8:00 AM EDT
This salt battery harvests osmotic energy where the river meets the sea
American Chemical Society (ACS)

Estuaries — where freshwater rivers meet the salty sea — are great locations for birdwatching and kayaking. In these areas, waters containing different salt concentrations mix and may be sources of sustainable, “blue” osmotic energy. Researchers in ACS Energy Letters report creating a semipermeable membrane that harvests osmotic energy from salt gradients and converts it to electricity. The new design had an output power density more than two times higher than commercial membranes in lab demonstrations.

21-Apr-2024 5:05 PM EDT
Perinatal Transmission of HIV Can Lead to Cognitive Deficits
Georgetown University Medical Center

Perinatal transmission of HIV to newborns is associated with serious cognitive deficits as children grow older, according to a detailed analysis of 35 studies conducted by Georgetown University Medical Center neuroscientists. The finding helps pinpoint the geographic regions and factors that may be important for brain development outcomes related to perinatal HIV infection: mother-to-child HIV transmission during pregnancy, labor and delivery, or breastfeeding.

Not for public release

This news release is embargoed until 29-Apr-2024 5:00 PM EDT Released to reporters: 23-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Apr-2024 5:00 PM EDT Released to reporters: 23-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Apr-2024 5:00 PM EDT Released to reporters: 23-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Magnetic Microcoils Unlock Targeted Single-Neuron Therapies for Neurodegenerative Disorders
18-Apr-2024 4:05 PM EDT
Magnetic Microcoils Unlock Targeted Single-Neuron Therapies for Neurodegenerative Disorders
American Institute of Physics (AIP)

In the Journal of Vacuum Science & Technology A, researchers deploy an array of microscopic coils to create a magnetic field and stimulate individual neurons. The magnetic field can induce an electric field in any nearby neurons, the same effect created by an electrode but much more precise. They used an array of eight coils, which combined can induce electric fields using much less current per coil, and employed soft magnetic materials, which boost the magnetic strength of the coils. The researchers constructed a prototype of their coil array, called MagPatch, and encapsulated it within a biocompatible coating.

   
Newswise: Laser-Treated Cork Absorbs Oil for Carbon-Neutral Ocean Cleanup
18-Apr-2024 8:05 AM EDT
Laser-Treated Cork Absorbs Oil for Carbon-Neutral Ocean Cleanup
American Institute of Physics (AIP)

In Applied Physics Letters, researchers use laser treatments to transform ordinary cork into a powerful tool for treating oil spills. They tested variations of a fast-pulsing laser treatment, closely examining the nanoscopic structural changes and measuring the ratio of oxygen and carbon in the material, changes in the angles with which water and oil contact the surface, and the material’s light wave absorption, reflection, and emission across the spectrum to determine its durability after multiple cycles of warming and cooling.

access_time Embargo lifts in 2 days
This news release is embargoed until 29-May-2024 9:00 AM EDT Released to reporters: 23-Apr-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-May-2024 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

20-Apr-2024 7:00 AM EDT
Stress Activates Brain Regions Linked to Alcohol Use Disorder, Differently for Women Than Men
Research Society on Alcoholism

When exposed to stress, people with alcohol use disorder engage parts of the brain associated with both stress and addiction, which may cause them to drink or crave alcohol after a stressful experience, suggest the authors of a study published in Alcohol: Clinical and Experimental Research.

     
22-Apr-2024 4:00 PM EDT
AANA Presents Excellence in State Government Relations Advocacy Award to Georgia
American Association of Nurse Anesthesiology

The American Association of Nurse Anesthesiology (AANA) honored the Georgia Association of Nurse Anesthetists (GANA) with the Excellence in State Government Relations Advocacy Award at its Mid-Year Assembly, held in Washington, D.C., April 20 – 24.

Not for public release

This news release is embargoed until 22-Apr-2024 5:00 PM EDT Released to reporters: 16-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 22-Apr-2024 5:00 PM EDT Released to reporters: 16-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 22-Apr-2024 5:00 PM EDT Released to reporters: 16-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   

Not for public release

This news release is embargoed until 22-Apr-2024 5:00 PM EDT Released to reporters: 16-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 22-Apr-2024 5:00 PM EDT Released to reporters: 16-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.



close
7.37542